Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

Board restructuring

9 May 2013 07:00

RNS Number : 2953E
First Derivatives PLC
09 May 2013
 



First Derivatives plc

("First Derivatives" or the "Company")

 

Establishment of Executive Management Committee and restructuring of Board of Directors

 

First Derivatives (AIM: FDP.L, ESM: GYQ.I), a leading provider of software and consulting services to the capital markets industry, announced today that the board has recently completed a review of the Company's decision making processes and announces the creation of an Executive Management Committee and a restructuring of the Company's Board of Directors.

 

First Derivatives floated on AIM in March 2002 and has since grown revenues from £1.8 million to £46.1m in the year to February 2012. During this period the Company has expanded from a single office in Newry, Co Down, employing 26 members of staff, to a global network of 10 offices employing over 720 people.

 

The Company is well positioned for continued expansion and further growth. In anticipation of this further growth the board has created a new management structure appropriate for a rapidly growing international business.

 

The board believes that the reorganisation of directors' and management's responsibilities better reflects the operational structure of the Company and also more closely reflects the provisions of the UK Corporate Governance Code.

 

Group management responsibilities will now be conducted through the recently-created Executive Management Committee. The composition of the Executive Management Committee reflects the organisational structure and central functions of the Company and is comprised of Brian Conlon, Graham Ferguson, Adrian Toner, Kevin Cunningham, Brendan Duffy, Gerry Buggy and Tom Kozlowski.

 

First Derivatives' Board of Directors will remain responsible for the strategic development of the Company, for all matters of corporate governance and related shareholder matters.

 

The Board will comprise:

David Anderson Non-Executive Chairman

Brian Conlon Chief Executive Officer

Graham Ferguson Chief Finance Officer

Pat Brazel Non-Executive Director

Keith MacDonald Non-Executive Director

Seamus Keating Non-Executive Director

 

Therefore, with immediate effect Adrian Toner and Kevin Cunningham, will resign as directors of the Company but will remain members of the Executive Management Committee.

 

Michael O'Neill will also resign with immediate effect from the Board of Directors. Michael joined First Derivatives in 1997, soon after its formation, and was instrumental in helping build the business to its current scale and global presence from both an operational and strategic perspective. He remained an Executive Director until 2009, and has continued since then to serve as a Non-Executive Director while developing his own business interests.

 

Commenting on Michael's resignation, Chief Executive Brian Conlon said: "I would like to thank Michael for the great service he has provided to First Derivatives over the last 16 years. The Company has grown beyond all recognition and Michael's vision and drive helped transform the Company from a small consulting organisation to a listed global software and services Company with a market capitalisation of more than £100m."

 

The board has also reviewed and amended the composition of the Remuneration Committee, as a result of which Brian Conlon will stand down and the committee will now comprise Pat Brazel (Chairman), Seamus Keating and David Anderson. The Audit Committee will comprise of Keith MacDonald (Chairman), Pat Brazel and Seamus Keating.

 

Commenting on the management restructuring David Anderson, Chairman, stated: "These changes address the need for a greater degree of structure and management flexibility within the Company as First Derivatives continues to expand into a global operating business. At the same time the board believes that the new structure also addresses the need for the Company to meet its obligations towards staff, shareholders and customers through more exacting standards of strong corporate governance."

 

 

For further information please contact:

 

First Derivatives plc +44(0)28 3025 2242

Brian Conlon, Chief Executive www.firstderivatives.com

Graham Ferguson, Chief Financial Officer

 

Charles Stanley Securities

(Nominated Adviser and Broker) +44 (0)20 7149 6000

Russell Cook

Carl Holmes

 

Goodbody Corporate Finance

(ESM Adviser and Broker) +353 1 667 0420

Diane Hodgson

Linda Hickey

 

Walbrook PR +44 (0)20 7933 8780

Bob Huxford bob.huxford@walbrookpr.com

Paul Cornelius paul.cornelius@walbrookir.com

 

 

About First Derivatives

First Derivatives is a global provider of software and consulting services to the financial services industry. With over 16 years experience working with leading financial institutions, it continues to deliver technologically advanced products and services that anticipate and respond to the evolving needs of global capital markets.

 

First Derivatives currently employs over 720 people worldwide and counts many of the world's top investment banks, brokers and hedge funds as its customers. It has operations in London, New York, Stockholm, Shanghai, Singapore, Toronto, Sydney, Dublin, Newry and Hong Kong.

 

For further information please visit www.firstderivatives.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBLGDULUGBGXI
Date   Source Headline
11th Feb 20144:18 pmRNSDirector's Shareholding
10th Feb 20147:00 amRNSIssue of Equity
6th Feb 20147:00 amRNSOpening of Singapore Office
20th Jan 20147:00 amRNSDirector/PDMR Shareholding
31st Dec 201311:08 amRNSTotal Voting Rights
20th Dec 20134:33 pmRNSIssue of Equity
5th Dec 20137:00 amRNSEnterprise Securities Market Notice
29th Nov 20134:00 pmRNSIssue of Equity
26th Nov 20137:00 amRNSASIC goes live with new surveillance system
5th Nov 20137:00 amRNSInterim Results
23rd Oct 20137:00 amRNSNotice of Results
30th Sep 20131:34 pmRNSTotal Voting Rights
18th Sep 20131:01 pmRNSCollaboration with NYSE Technologies
11th Sep 20137:00 amRNSEnterprise Securities Market Notice
10th Sep 20137:00 amRNSContract Win
5th Sep 20132:41 pmRNSIssue of Equity
30th Aug 20131:05 pmRNSTotal Voting Rights
21st Aug 20137:00 amRNSDelta Stream Selected by Communications Provider
14th Aug 20137:00 amRNSEnterprise Securities Market Notice
8th Aug 201312:53 pmRNSIssue of Equity
18th Jul 201312:55 pmRNSResult of AGM
9th Jul 20137:00 amRNSEnterprise Securities Market Notice
5th Jul 20134:11 pmRNSHolding(s) in Company
5th Jul 20134:10 pmRNSHolding(s) in Company
3rd Jul 20133:18 pmRNSIssue of Equity
3rd Jul 20137:00 amRNSEnterprise Securities Market Notice
28th Jun 20137:00 amRNSPlacing of 840,000 new ordinary shares
18th Jun 20137:00 amRNSFinal Results
5th Jun 20137:00 amRNSNotice of Results
9th May 20137:00 amRNSBoard restructuring
30th Apr 20138:00 amRNSTotal Voting Rights
26th Apr 20133:54 pmRNSEnterprise Securities Market Notice
23rd Apr 20137:00 amRNSEnterprise Securities Market Notice
19th Apr 20137:30 amRNSChange in Directors Shareholding
19th Apr 20137:30 amRNSGrant of Options
17th Apr 20133:10 pmRNSIssue of Equity
3rd Apr 20133:40 pmRNSDirector's Shareholding
2nd Apr 20137:00 amRNSPre-close period trading update
15th Mar 20137:00 amRNSSEF initiative & Compliance Officer appointment
28th Feb 20137:00 amRNSTotal Voting Rights
11th Feb 20137:00 amRNSEnterprise Securities Market Notice
6th Feb 20137:00 amRNSExercise of Options
4th Jan 20133:41 pmRNSDirector/PDMR Shareholding
13th Dec 20127:00 amRNSContract win
10th Dec 20127:00 amRNSDirectorate Change
30th Nov 20127:00 amRNSTotal Voting Rights
16th Nov 20127:00 amRNSEnterprise Securities Market Notice
14th Nov 20127:00 amRNSDirector shareholding
13th Nov 20127:00 amRNSDirector shareholding
12th Nov 20123:24 pmRNSExercise of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.